Org.nr 990 646 066 2010 → 2011 Year-over-year analysis

NYKODE THERAPEUTICS ASA: årsregnskap 2011 vs 2010

Grew 2489% on revenue

approved 2012-05-16; registry 2012-09-13; journal 2012 775018

Summary

What changed

Comparing Årsregnskap 2011 with 2010 for NYKODE THERAPEUTICS ASA. Revenue 51.0k NOK → 1.32m NOK (+2488.9%). Equity 2.93m NOK → 340.8k NOK.

On the constructive side: revenue rose; operating result improved; cash rose. Pressures included: equity eroded.

Also worth watching: thin equity buffer; payroll increased. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.

At a glance

Revenue

51.0k NOK 1.32m NOK

+2488.9%

Operating result

-2.85m NOK -2.51m NOK

+11.9%

Equity

2.93m NOK 340.8k NOK

-88.4%

Cash

2.53m NOK 2.61m NOK

+3.1%

Total assets

3.96m NOK 4.76m NOK

+20.2%

↑
Revenue rose

Operating income / revenue moved from 51.0k NOK to 1.32m NOK (+2488.9% YoY). Calculated
↑
Operating result improved

Operating result -2.85m NOK → -2.51m NOK (op. margin -5582.3% → -190.0%). Calculated
↑
Cash rose

Bank deposits 2.53m NOK → 2.61m NOK (+3.1% YoY). Calculated

↓
Equity eroded

Book equity 2.93m NOK → 340.8k NOK (equity ratio 73.9% → 7.2%). Calculated

·
Thin equity buffer

Equity ratio is 7.2% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
·
Payroll increased

Salary cost 261.2k NOK → 600.5k NOK (512% → 45% of revenue). Calculated